Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-09-20
2000-10-31
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514529, 514544, 514617, 514625, 514640, A61K 3115, A61K 3116, A61K 31165, A61K 31235, A61K 31415
Patent
active
061403563
ABSTRACT:
Ophthalmic pharmaceutical compositions containing a pharmaceutically acceptable ophthalmic carrier and an inflammation-treating amount of a nitrone compound are disclosed. Also disclosed are methods for treating ocular inflammation conditions, such as uveitis, using pharmaceutical compositions.
REFERENCES:
patent: 4153722 (1979-05-01), Campbell et al.
patent: 5025032 (1991-06-01), Carney et al.
patent: 5036097 (1991-07-01), Floyd et al.
patent: 5527828 (1996-06-01), Janzen et al.
patent: 5532277 (1996-07-01), Janzen et al.
Chan C, Ni M, Miele L, Cordella-Miele E, Ferrick M, Mukherjee A, and Nussenblatt R., Effects of Antiflammins on Endotoxin-induced Uveitis in Rats, Arch Ophthalmal109, 278-281 (1991).
Goto H, Wu GS, Chen F, Kristeva M, Sevanian A, And Rao NA., Lipid Peroxidation in Experimental Uveitis: Sequential Studies, Curr Eye Res, 11(6), 489-499 (1992).
Goto H., Retinal Tissue Damage and Lipid Peroxidation in Experimental Autoimmune Uveoretinitis, Nippon Ganka Gakka Zasshi, 95, 455-461 (1991).
Hu S, Li S, Pan S, Xie C, Huang X and Mao W., Effect of Superoxide Dismutase on Experimental Allergic Uveitis, Yen Ko Hsueh Poa, 9, 103-105 (1993).
Kasner L, Chan C, Cordella-Miele E, and Gery, I., The Effect of Chlorpromazine on Endotoxin Induced Uveitis in the Lewis Rat, Curr Eye Res, 11(9), 843-848 (1992).
Nussenblatt RB, Rodrigues MM, Wacker WB, Cevario SJ, and Salinas-Carmona MC., Cylosporin A: Inhibition of Experimental Autoimmune Uveitis in Lewis Rats, J. Clin Invest, 67, 1228-1231 (1981).
Nussenblatt R, Caspi R, Mahdi R, Chan C, Roberge F, Lider O, and Weiner H., Inhibition of S-antigen Induced Experimental Autoimmune Uveoretinitis by Oral Induction of Tolerance with S-antigen, J Immunol, 144, 1689-1695 (1990).
Parks DJ, Cheung MK, Chan CC, and Roberge FG., The Role of Nitric Oxide in Uveitis, Arch Ophthalmol, 112, 544-546 (1994).
Rao NA, Patchett R, Fernandez MA, Sevanian A, Kunkel SL, and Marak GE., Treatment of Experimental Granulomatous Uveitis by Lipoxygenase and Cyclooxygenase Inhibitors, Arch Ophthalmol, 105, 413-415 (1987).
Rao N., Role of Oxygen Free Radicals in Retinal Damage Associated with Experimental Uveitis, Tr Am Ophth Soc, 88, 797-850 (1990).
Ruiz-Moreno J, Misiuk-Hojlo M, Thillaye B, and de Kozak Y., Suppression of Experimental Autoimmune Uveoretinitis. by Prazosin, an .alpha..sub.1 -adrenergic, Curr Eye Res, 11 suppl, 135-140 (1992).
Tilton RG, Chang K, Corbett JA, Misko TP, Currie MG, Bora NS, Kaplan HJ, and Williamson JR., Endotoxin-induced Uveitis in the Rat is Attenuated by Inhibition of Nitric Oxide Production, Invest Ophthalmol Vis Sci, 35(8), 3278-3288 (1994).
Uchio E, Kijima M, Tanaka S and Ohno S., Suppression of Experimental Uveitis with Monoclonal Antibodies to ICAM-1 and LFA-1, Invest Ophthalmol Vis Sci, 35, 2626-2631 (1994).
Wu GS, Sevanian A. and Rao NA., Detection of Retinal Lipid Hydroperoxides in Experimental Uveitis, Free Radical Biol Med, 12, 19-27 (1992).
Wu GS, Goto H, Sevanian A, and Rao NA., Generation of Chemiluminescence in Experimental Autoimmune Uveitis, Curr Eye Res,10, 909-917 (1991).
Wu GS, Walker J, and Rao NA., Effect of Deferoxamine on Retinal Lipid Peroxidation in Experimental Uveitis, Invest Ophthalmol Vis Sci, 34, 3084-3089 (1993).
Carney John Michael
Duzman Efraim
Narducy Kenneth W.
Wilcox Allan Lee
Centaur Pharmaceuticals, Inc.
Rotman Alan L.
LandOfFree
Opthalmic pharmaceutical compositions comprising a nitrone compo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Opthalmic pharmaceutical compositions comprising a nitrone compo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Opthalmic pharmaceutical compositions comprising a nitrone compo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2052260